Cargando…
The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation
In recent years, due to the aging of the population and the development of diagnostic medicine, the number of identified diseases associated with the accumulation of amyloid proteins has increased. Some of these proteins are known to cause a number of degenerative diseases in humans, such as amyloid...
Autores principales: | Galzitskaya, Oxana V., Grishin, Sergei Y., Glyakina, Anna V., Dovidchenko, Nikita V., Konstantinova, Anastasiia V., Kravchenko, Sergey V., Surin, Alexey K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964835/ https://www.ncbi.nlm.nih.gov/pubmed/36835194 http://dx.doi.org/10.3390/ijms24043781 |
Ejemplares similares
-
Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments
por: Galzitskaya, Oxana V., et al.
Publicado: (2018) -
Determination of amyloid core regions of insulin analogues fibrils
por: Surin, Alexey K., et al.
Publicado: (2020) -
Prediction of Residue Status to Be Protected or Not Protected From Hy-drogen Exchange Using Amino Acid Sequence Only
por: Dovidchenko, Nikita V, et al.
Publicado: (2008) -
New Model for Stacking Monomers in Filamentous Actin from Skeletal Muscles of Oryctolagus cuniculus
por: Glyakina, Anna V., et al.
Publicado: (2020) -
Amyloidogenic Peptides: New Class of Antimicrobial Peptides with the Novel Mechanism of Activity
por: Galzitskaya, Oxana V., et al.
Publicado: (2022)